Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 42 % of short-term debt in 2024; threshold 65 %.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2024
ARTIALIS from Liège, company number BE0830584472, closed financial year 2024 with a result of € -1.2 million after tax. For that financial year ARTIALIS recorded a gross margin of € 320,267 and equity of € 235,767. Compared with financial year 2023, the result moved from € -1.7 million to € -1.2 million. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 14, 2025.
€ 235,767
▼ 49% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.2 million
▲ 28 % less loss than in 2023
Profit after tax over the fiscal year.
€ 99,064
▼ 4% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.6 million.
People and assets in 2024
13.6
▼ 1.6 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 1.2 million
▲ 1% vs 2023
€ 86,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,185
▼ 45% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 264,000
▲ 197% vs 2023
Loans from banks and other lenders, long and short.
€ 197,835
▼ 76% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 209,084
▲ 9% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 2,184,113 | € 1,360,062 | € 136,282 | € 320,267 | ▲ 135% |
| Profit after taxes | € 429,796 | € 21,343 | € -1,694,788 | € -1,225,757 | ▲ € 469,031 |
| Equity | € 2,132,709 | € 2,154,052 | € 459,264 | € 235,767 | ▼ 49% |
| Total debts | € 792,332 | € 910,642 | € 1,707,524 | € 1,479,968 | ▼ 13% |
| Cash | € 504,989 | € 12,326 | € 103,349 | € 99,064 | ▼ 4% |
| Retained profit | € 1,329,231 | € 1,350,574 | € -344,213 | € -1,569,971 | ▼ € 1.2 million |
| Bank debt | € 323,902 | € 140,730 | € 89,007 | € 264,000 | ▲ 197% |
| Balance sheet total | € 2,925,041 | € 3,064,695 | € 2,166,788 | € 1,715,735 | ▼ 21% |
| Employees (FTE) | 11.5 | 14.9 | 15.2 | 13.6 | ▼ 1.6 |
Key figures of ARTIALIS, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to ARTIALIS?
What happened at ARTIALIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
ARTIALIS is active according to the CBE. Legal situation: Opening faillissement.
- NOSHAQ PARTNERS SRL stepped down as director. NBB
- VENTURE COACHING SC stepped down as director. NBB
- BEST CLINICAL PRACTICE stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 1.2 million. Source: NBB ↗
- NOSHAQ PARTNERS SRL became a director. NBB
- VENTURE COACHING SC became a director. NBB
- BEST CLINICAL PRACTICE became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 429,796 profit in 2021 to € 1.2 million loss in 2024.
Best year ever: 2021, with € 429,796 profit.
On average € 23,500 of value added per employee in 2024.
A new publication or filing at ARTIALIS? We notify you, reason included.
Follow ARTIALISDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Best Clinical Practice, NOSHAQ, FleXXimum R & D comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
ARTIALISThe shares are held by Best Clinical Practice (143.4%), NOSHAQ (34.6%) and FleXXimum R & D (21.5%).
Directors
According to the 2024 annual accounts
Director · represented by SABATEL HÉLÈNE
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE, SOGECOM, VITAVERDE.BIO, HAEMERS Technologies, SPACEBEL, NOSHAQ VENTURE +169 more
since 2024 · until 2030
Director · represented by Nathalie Benoit
Also active at: MICROBELCAPS, NOSHAQ SPIN-OFFS, PRESSES UNIVERSITAIRES DE LIEGE, SCIENCE PARK SERVICES, PHYTESIA, AGROPTIMIZE, Green SURF, Cytomine +11 more
since 2024 · until 2030
Director · represented by Van NIEUWENHOVE BENEDIKT
Also active at: EUROPEAN CENTRE FOR CLINICAL RESEARCH TRAINING
since 2024 · until 2030
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Avenue Hippocrate 5
4000 Liège
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →XeroThera Europe
€ 196,870 gross margin · 2025
Sagitta Biotech same network
€ -138,661 gross margin · 2025
QUIDDITAS
€ 175,986 gross margin · 2025
Temple OrthoBiologics
€ -225,322 gross margin · 2025
BRENUS PHARMA BELGIUM
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
AUTOMATTIC - Automattic, Inc, US
DNS
OVH DNS
Domain
Domain
artialis.com
Registered
2009-03-20
Registrar
eNom, LLC
Expires
2027-03-20
Website info
Features
Security
Network
Details
- Company number
- 0830.584.472
- VAT number
- BE 0830.584.472
- Registered office
- Avenue Hippocrate 5, 4000 Liège
- Names & denominations
- ARTIALIS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 25 October 2010
- Peppol
- Active · Active since 14 Oct 2025
- Contact
- artialis.com
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten